Polarean Imaging is a clinical stage medical imaging technology company developing a proprietary magnetic resonance imaging (MRI) drug-device combination.
Polarean is manufacturer and service provider for noble gas polarizer devices and ancillary instruments with special focus on pulmonary imaging using hyperpolarized gas MRI.
Polarean Imaging was founded in 2016 by Bastiaan Driehuys. The company is headquartered in Research Triangle Park, North Carolina.
Polarean Imaging develops equipment that enables existing MRI systems to achieve an improved level of pulmonary function imaging and specializes in the use of hyperpolarized Xenon gas (129Xe) as an imaging agent to visualize ventilation.129Xe gas is currently being studied for visualization of gas exchange regionally in the smallest airways of the lungs.
Polarean Imaging also develops and manufactures high performance MRI radiofrequency (RF) coils which are a required component for imaging 129Xe in the MRI system.
Polarean Imaging is backed by Bracco Imaging, along with others. The company has conditionally raised £8.4M ($10.7M) on Mar 13, 2020. This brings Polarean's total funding to $12.6M to date.